NCT00096278View on ClinicalTrials.gov

Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer

PHASE3CompletedINTERVENTIONAL

Enrollment

2,710

Participants

Timeline

Start Date

September 15, 2004

Primary Completion Date

March 12, 2009

Study Completion Date

December 31, 2012

Conditions

Colon AdenocarcinomaStage IIA Colon Cancer AJCC v7Stage IIB Colon Cancer AJCC v7Stage IIC Colon Cancer AJCC v7Stage IIIA Colon Cancer AJCC v7Stage IIIB Colon Cancer AJCC v7Stage IIIC Colon Cancer AJCC v7

Interventions

BIOLOGICAL

Bevacizumab

Given IV

DRUG

Fluorouracil

Given IV

DRUG

Leucovorin Calcium

Given IV

DRUG

Oxaliplatin

Given IV

Trial Locations (1)

15212-5234

National Surgical Adjuvant Breast and Bowel Project, Pittsburgh

All Listed Sponsors

collaborator

NSABP Foundation Inc

NETWORK

lead

National Cancer Institute (NCI)

NIH

NCT00096278 - Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer | Biotech Hunter | Biotech Hunter